Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
208.99
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,756
Open
208.99
Bid (Size)
209.25 (100)
Ask (Size)
209.88 (500)
Prev. Close
208.99
Today's Range
208.99 - 208.99
52wk Range
168.54 - 244.81
Shares Outstanding
N/A
Dividend Yield
3.31%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why AbbVie Is a No-Brainer Stock to Buy on the Dip
↗
April 16, 2026
The pharma giant is still a rock-solid dividend stock.
Via
The Motley Fool
1 Value Stock Worth Your Attention and 2 That Underwhelm
April 16, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via
StockStory
Performance
YTD
-8.9%
-8.9%
1 Month
-4.9%
-4.9%
3 Month
-3.6%
-3.6%
6 Month
-7.9%
-7.9%
1 Year
+21.7%
+21.7%
More News
Read More
3 High-Yielding Dividend Stocks to Buy, Even If You're Worried About the Market
↗
April 15, 2026
Via
The Motley Fool
Could AbbVie Crash Lilly's Weight‑Loss Party?
↗
April 14, 2026
Via
The Motley Fool
The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
April 14, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
This Indicator Has Called Every Recession Over the Last 80 Years. Here's What It's Saying Now.
↗
April 14, 2026
Via
The Motley Fool
Topics
Economy
2 S&P 500 Stocks with Solid Fundamentals and 1 We Brush Off
April 14, 2026
Via
StockStory
Topics
Stocks
The Science of Scale: An In-Depth Look at Regeneron Pharmaceuticals (REGN) in 2026
April 13, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
S&P 500 Index Dividend Yields Are Teasing All-Time Lows. Here Are 3 Dividend Darlings That Crush This Trend.
↗
April 13, 2026
Via
The Motley Fool
Topics
Stocks
3 Market-Beating Stocks with Competitive Advantages
April 10, 2026
Via
StockStory
Gilead Sciences Solidifies Oncology Future with $5 Billion Acquisition of ADC Innovator Tubulis
April 09, 2026
Via
MarketMinute
Topics
Bonds
3 Dividend Aristocrats Whose Yields Can Help Combat Inflation
↗
April 09, 2026
Via
MarketBeat
Topics
Economy
3 Companies Aggressively Raising Dividends While Others Play Defense
↗
April 09, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Economy
This Investor's $5 Million ETF Buy Pushes 2028 Bond Fund to Nearly 4% of AUM
↗
April 09, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Regulatory Compliance
This Fund's Ladder Strategy Expanded With a $4 Million Buy in One 2027 Bond ETF
↗
April 09, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Red Spruce Adds $3.35 Million to a 2029 Bond ETF With 4.5% Yield. Here's What Investors Should Know
↗
April 09, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Regulatory Compliance
1 Healthcare Stock on Our Watchlist and 2 We Avoid
April 09, 2026
Via
StockStory
3 Absurdly Cheap Dividend Stocks to Buy in April 2026
↗
April 08, 2026
Via
The Motley Fool
Topics
Economy
This Pharma Dividend Has Been Raised Every Single Year for Over a Decade
↗
April 07, 2026
Via
The Motley Fool
Topics
Intellectual Property
Should You Buy AbbVie Stock Before April 29?
↗
April 07, 2026
Via
The Motley Fool
Topics
Intellectual Property
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
April 06, 2026
Via
MarketMinute
Topics
Economy
World Trade
Regeneron Pharmaceuticals: The Scientific Juggernaut Navigating a High-Stakes Transformation
April 03, 2026
Via
Finterra
Topics
Economy
Intellectual Property
World Trade
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory
↗
April 02, 2026
Via
The Motley Fool
Topics
Economy
Retirement
Stocks
Merck’s Oncology Empire Expands: Keytruda Secures Pivotal European Commission Approval for Recurrent Ovarian Cancer
April 02, 2026
Via
MarketMinute
Topics
Intellectual Property
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know
April 02, 2026
Via
StockStory
Topics
Government
Stocks
World Trade
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 208.99
When was AbbVie last traded?
The last trade of AbbVie was at 04/16/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.